Investors & Media

Investor Presentations

Scientific Presentations

ACAAI 2022 Poster 006

Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey

Download >

ACAAI 2022 Poster 008

Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey

Download >

ACAAI 2022 Poster 236

Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis

Download >

ACAAI 2022 Poster 237

ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors

Download >

ACAAI 2022 Poster 238

Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection

Download >

ACAAI 2020 Poster 008

Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey

Download >

AAAAI 2022 Poster 007

Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi

Download >

AAAAI 2022 Poster 008

Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors

Download >

AAAAI 2022 Poster 009

The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy ) Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis

Download >

AAAAI 2020 Poster 022

Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions

Download >

ACAAI 2022 Poster 006

Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey

Download >

ACAAI 2022 Poster 008

Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey

Download >

ACAAI 2022 Poster 236

Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis

Download >

ACAAI 2022 Poster 237

ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors

Download >

ACAAI 2022 Poster 238

Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection

Download >

AAAAI 2022 Poster 007

Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi

Download >

AAAAI 2022 Poster 008

Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors

Download >

AAAAI 2022 Poster 009

The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy ) Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis

Download >

AAAAI 2020 Poster 022

Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions

Download >